ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
FDA grants fast review to AZ cancer drug
pharmaphorum
August 03, 2017The FDA is to give AstraZeneca’s cancer drug acalabrutinib a fast review in a rare blood cancer, as the company hopes to shake off disappointing results from a crucial lung cancer trial last week.
Pharma Sources Insight January 2025
